by ADRIAN FREDERICK MANZ Manz | Jan 6, 2026 | The Doctor's Dose
How to Stop FOMO in Trading: When a “Right Trade” Becomes a Losing Trade Sometimes the trade idea is right… and the trader still loses. The culprit is often simple: entry discipline gets replaced by urgency. How to Stop FOMO in Trading Starts With One Truth: The Entry...
by ADRIAN FREDERICK MANZ Manz | Jan 4, 2026 | The Doctor's Dose
The Impact of Venezuela Sanctions on Traders: What Markets May React to This Week Geopolitical headlines don’t need to trigger a crisis to matter. Often, the real impact of Venezuela sanctions on traders comes from how uncertainty alters expectations, volatility, and...
by ADRIAN FREDERICK MANZ Manz | Jan 4, 2026 | The Doctor's Dose
Trader Psychology for the Week Ahead: A Weekend Reset for Clarity, Energy, and Expectation Control The best trading weeks don’t start on Monday — they start with how you recover on the weekend. Trader psychology for the week ahead is about arriving at the opening bell...
by ADRIAN FREDERICK MANZ Manz | Jan 2, 2026 | The Doctor's Dose
Tesla Loses Its Crown: What BYD’s Rise Means for TSLA Traders Focus keyphrase: Tesla sales decline trading impact Tesla is no longer the top global EV seller. After posting a second consecutive annual decline in deliveries, Tesla has been surpassed in EV sales by...
by ADRIAN FREDERICK MANZ Manz | Dec 31, 2025 | The Doctor's Dose
China’s AI Advances Are Back — and Traders Should Care Just as U.S. markets were waiting for the next leg higher in AI leadership stocks, China has reintroduced a familiar wildcard. Reports of a photon-based computing chip for AI training and inference—dubbed...
by ADRIAN FREDERICK MANZ Manz | Dec 30, 2025 | The Doctor's Dose
The Hidden Perils of Pre- and Post-Holiday Trading Why the Open Is the Only Liquidity That Matters Holiday trading weeks lure traders into a dangerous illusion. The screens are on. The market is open. Prices are moving. So it feels like opportunity. But in reality,...
by ADRIAN FREDERICK MANZ Manz | Dec 30, 2025 | The Doctor's Dose
AI Chip Boom Enters Its Most Important Phase: Opportunity, Competition, and Risk The global semiconductor industry just posted its largest year on record. Driven by explosive growth in artificial intelligence, the world’s largest chipmakers generated more than $400...
by ADRIAN FREDERICK MANZ Manz | Dec 29, 2025 | The Doctor's Dose
When the Santa Claus Rally Fails: What Traders Should Focus On Instead The stock market erased its Santa Claus rally gains on Monday as Wall Street moved decisively into risk-off mode. The Nasdaq Composite fell 0.5%, the S&P 500 dropped 0.4%, and the Dow Jones...
by ADRIAN FREDERICK MANZ Manz | Dec 26, 2025 | The Doctor's Dose
Why “Getting Back to Breakeven” Is So Dangerous On the surface, breakeven feels reasonable. Responsible, even. “I’m not trying to make money—just get back to flat.” But psychologically, breakeven is a trap. Here’s why: You’re now anchored to a past loss You’re...
by ADRIAN FREDERICK MANZ Manz | Nov 19, 2025 | The Doctor's Dose
Target Slashes Guidance Again as Sales Decline — A Turning Point for the Retail Giant? Target reported another disappointing quarter, with sales falling for the fourth straight period, and management issued yet another earnings guidance cut. The retailer now faces a...
